Depression in children and adolescents

• Authors: Agnieszka Słopień

Abstracts

EN

In recent years, the situation of child and adolescent psychiatry in Poland has dramatically deteriorated. 24-hour psychiatric wards dedicated to minors are overcrowded and it is almost exclusively patients who are a direct threat to their own health or life that are hospitalised. About 20% of children and adolescents have symptoms of various mental disorders, of which 10% (about 400,000) require specialist care. Depression is one of the most common health problems among children and adolescents and its prevalence increases with age and puberty. Depression can be chronic, with constant severity, or recurrent, when symptoms return in the form of mild, moderate or severe episodes. The mood disorders occurring in the developmental period carry many negative consequences in the emotional, social and educational functioning of the patient. They increase the risk of self-destructive behaviours, suicide, abuse of psychoactive substances, as well as later difficulties in many areas of life during adulthood.

Keywords

EN

children and adolescents; depression; mood disorders

PL

depresja; dzieci i młodzież; zaburzenia nastroju

• Publisher: Uniwersytet Jagielloński
• Journal: Zdrowie Publiczne i Zarządzanie
• Year: 2019
• Volume: 17
• Issue: 1
• Pages: 26-31

Dates

published

2019

Contributors

author

Agnieszka Słopień

• Klinika Psychiatrii Dzieci i Młodzieży, Szpital Kliniczny im. Karola Jonschera Uniwersytetu Medycznego im. Karola Marcinkowskiego w Poznaniu

• https://orcid.org/0000000178218972

References

• Maślankiewicz R., Bójko M., Raport Watchdoga – Jak źle jest w polskiej psychiatrii dzieci i młodzieży?, 2019; https:// siecobywatelska.pl/raport-watchdoga-jak-zle-jest-w-polskiej-psychiatrii-dzieci-i-mlodziezy/ (accessed: 23.08.2019).
• Szredzińska R., Dzieci się liczą. Raport o zagrożeniach bezpieczeństwa i rozwoju dzieci w Polsce, “Dziecko Krzywdzone. Teoria, Badania, Praktyka” 2017; 16 (1): 112–117.
• Kieling C., Baker-Henningham H., Belfer M., Conti G., E tem I., Omigbodun O., Rohde L.A., Srinath S., Ulkuer N., Rahman A., Child and adolescent mental health worldwide: Evidence for action, “Lancet” 2011; 378 (9801): 1515–1525.
• Manual of the International Statistical Classification of the Diseases and Related Health Problems, 10th Edition, World Health Organization, Geneva 2002.
• Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), American Psychiatric Association, Washington, DC 2013.
• Costello E.J., Mustillo S., Erkanli A. et al., Prevalence and development of psychiatric disorders in childhood and adolescence, “Arch. Gen. Psychiatry” 2003; 60: 837–844.
• Olsson G.I., von Knorring A.-L., Adolescent depression: prevalence in Swedish high-school students, “Acta Psychiatr. Scand.” 2007; 99: 324–331.
• Merikangas K.R., Jian ping-He, Burstein M. et al., Lifetime prevalence of mental disorders in U.S. adolescents: Results from the National Comorbidity Survey Replication-Adolescent Supplement (NCS-A), “J. Am. Acad. Child Adolesc. Psychiatry” 2010; 49: 980–989.
• Jellinek M.S., Snyder J.B., Depression and suicide in children and adolescents, “Pediatr. Rev.” 1998; 19: 255–264.
• Richardson L.P., Katzenellenbogen R., Childhood and adolescent depression: The role of primary care providers in diagnosis and treatment, “Curr. Probl. Pediatr. Adolesc. Health Care” 2005; 35 (1): 6–24.
• Birmaher B., Arbelaez C., Brent D., Course and outcome of child and adolescent major depressive disorder, “Child Adolesc. Psychiatr. Clin. N. Am.” 2002; 11 (3): 619–637.
• Klein D.N., Schwartz J.E., Rose S., Leader J.B., Five-year course and outcome of dysthymic disorder: A prospective, naturalistic follow-up study, “Am. J. Psychiatry” 2000; 157 (6): 931–939.
• McClellan J., Werry J., Practice parameters for the assessment and treatment of children and adolescents with bipolar disorder, “J. Am. Acad. Child Adolesc. Psychiatry” 1997; 36 (1): 138–157.
• Lewinsohn P.M., Klein D.N., Seeley J.R., Bipolar disorders in a community sample of older adolescents: Prevalence, phenomenology, comorbidity, and course, “J. Am. Acad. Child Adolesc. Psychiatry” 1995; 34 (4): 454–463.
• Greszta E., Rodzinne czynniki ryzyka rozwoju depresji u dorastających, “Psychiatr. Pol.” 2006; 4: 719–730.
• Rabe-Jabłońska J., Zaburzenia afektywne u dzieci i młodzieży, in: Pużyński S., Rybakowski J., Wciórka J. (eds.), Psychiatria. Psychiatria kliniczna, Elsevier Urban & Partner, Wrocław 2011: 377–380.
• Spitz R.A., Anaclitic depression: An inquiry into the genesis of psychiatric conditions in early childhood, “Psychoanal. Study Child” 1946; 2: 313–342.
• Namysłowska I., Zaburzenia psychiczne dzieci i młodzieży. Wybrane zagadnienia, Polskie Towarzystwo Psychologiczne, Kraków 2000.
• Benazzi F., Is there a link between atypical and early-onset “unipolar” depression and bipolar II disorder? “Compr. Psychiatry” 2003; 44 (2): 102–109.
• Carr A., Depresja i próby samobójcze młodzieży. Sposoby przeciwdziałania i reagowania, Gdańskie Wydawnictwo Psychologiczne, Gdańsk 2004.
• Geller B., Zimerman B., Williams M., Bolhofner K., Craney J.L., Delbello M.P., Soutullo C.A., Six-month stability and outcome of a prepubertal and early adolescent bipolar disorder phenotype, “J. Child Adolesc. Psycho-pharmacol.” 2000; 10 (3): 165–173.
• Heron M., Deaths: Leading causes for 2010, “Natl. Vital Stat. Rep.” 2013; 62 (6): 1–96.
• Treatment for Adolescents with Depression Study (TADS) Team: Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression. Treatment for adolescents with depression study (TADS) randomized controlled trial, “JAMA” 2004; 292: 807.
• Lambert M., Niehaus V., Correll C., Pharmacotherapy in children and adolescents at clinical-high risk for psychosis and bipolar disorder, “Pharmacopsychiatry” 2016; 49 (6): 229–244.
• Emslie G.J., Heiligenstein J.H., Wagner K.D. et al., Fluoxetine for acute treatment of depression in children and adolescents: A placebo-controlled, randomized clinical trial, “J. Am. Acad. Child Adolesc. Psychiatry” 2002; 41 (10): 1205–1215.

Identifiers

DOI

10.4467/20842627OZ.19.004.11300

Biblioteka Nauki

2188039